More focus will be on gene and immune therapy
Data and AI will continue to play a key role in the mapping of genes
Governments around the world need to address gaps with their healthcare delivery model
WHO needs to do a better job mitigating the spread of diseases and variants?
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - September ...paul young cpa, cga
This document provides an overview and agenda for a presentation on the biotech, pharmaceutical, and healthcare sector. It includes:
- An introduction and biography of presenter Paul Young CPA CGA
- An agenda covering topics like vaccine production, drug discovery, innovation in areas like storage and AI, and the life sciences strategy
- Links and summaries of information on these topics, including the top vaccine manufacturers, regulations in Canada, and growth in the pharmaceutical market
The presentation aims to discuss key areas of the biotech/pharmaceutical sector including vaccine development and production, drug discovery, innovation, and strategies for the life sciences industry. Links and outside sources are provided to support the topics in the agenda.
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - May 2023.pptxpaul young cpa, cga
Blog – Pharmaceutical Biotech Medical Supplies and Equipment – Analysis – May 2023
Summary:
Healthcare, pharma, and biotech continue to look at how best to deploy data and AI as part of their various product lifecycles.
Healthcare continues to look at ways to automate various operational aspects. The key will be how to secure, store, and ingest the data as part of improving patient outcome.
EMEA counties to move forward with key policy changes like DORA, CRA, and ESG reporting.
Biotech^J Pharmaceutical^J and Healthcare Sector - March 2023.pptxpaul young cpa, cga
Blog – Healthcare and Pharmaceutical Sector Analysis – March 2023
Summary
Healthcare systems around the world continue to face many challenges
Additional sources:
AI and the pharmaceutical sector - https://www.linkedin.com/pulse/ai-pharmaceutical-market-giants-spending-going-boom-abbvie-pimpalkar/
AI and Automation - https://accelerationeconomy.com/ai/how-ai-and-automation-enhance-healthcare-from-medical-diagnosis-to-supply-chains/
Continue support of health and wellness programs as part of managing the overall healthcare sector is key area as part of improving patient outcomes. https://www.globenewswire.com/en/news-release/2023/03/31/2638434/0/en/Nurturing-a-Healthier-World-The-Health-and-Wellness-Market-Scaling-New-Heights-Driven-by-Growing-Demand-for-Sustainable-and-Natural-Products.html
Automating the care management model will be key to delivering better healthcare outcomes - https://www.globenewswire.com/news-release/2023/03/30/2637293/0/en/Care-Management-Market-Is-Expected-to-Reach-USD-33-3-Billion-by-2030-Grow-at-a-CAGR-Of-14-41-during-Forecast-Period-2023-To-2030-Data-By-Contrive-Datum-Insights-Pvt-Ltd.html
Managing healthcare costs as part of delivering better patient outcomes has been a challenge for governments around the world - https://www.kff.org/health-costs/issue-brief/how-does-medical-inflation-compare-to-inflation-in-the-rest-of-the-economy/
Adopting a digital model continues to be challenge for healthcare providers - https://techupforwomen.com/qa-cost-is-the-most-significant-barrier-to-digital-health-adoption/
Healthcare continues to look at ways to adopt technology - https://www.odgersinterim.com/us/who-we-are/intelligence/the-power-of-technology-to-transform-healthcare-5174/ and https://www.jabil.com/blog/connected-health-technology-trends.html
Synthetic data and healthcare - https://mostly.ai/blog/healthcare-data-platform/
Data and AI - https://www.healthcareitnews.com/news/data-analytics-platform-and-integrated-tools
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - June 2023....paul young cpa, cga
Blog – Pharma Healthcare and Biotech – Commentary and Analysis – June 2023
1. Limited market understanding
2. Regulatory compliance
3. Limited marketing budget
4. Long sales cycle
5. Communication of Scientific Complexity
Source - https://www.linkedin.com/pulse/navigating-marketing-challenges-biotech-industry-solutions-satya/
Additional sources and links:
ESG and Sustainability - https://www.hospitalmanagement.net/dashboards/filings/environmental-sustainability-mentions-healthcare-industry/ or https://www.pharmaceutical-technology.com/sponsored/the-rise-and-rise-of-esg-in-the-pharmaceutical-sector-is-a-zero-waste-supply-chain-possible/ or
Trusted AI - https://www.csis.org/analysis/path-trustworthy-ai-g7-outcomes-and-implications-global-ai-governance
Drug costs - https://www.healthaffairs.org/content/forefront/medicare-drug-price-negotiation-few-drugs-big-impact
Patents - https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-pfizer-hit-with-new-patent-lawsuits-over-covid-vaccines-2023-06-06/
Globalization - https://www.rbcwealthmanagement.com/en-asia/insights/worlds-apart-risks-and-opportunities-as-deglobalization-looms
Healthcare - https://www.globsec.org/what-we-do/commentaries/bridging-healthcare-gap-solidarity-and-investment-east-west-equality
Medical top technologies - https://healthnews.com/family-health/healthy-living/wearable-medical-devices-used-in-healthcare/ or
Challenges - https://www.nasdaq.com/articles/3-key-biotech-trends-for-2023-and-beyond
Digital - https://www.valtech.com/industries/health/?utm_content=linkedin_retargeting&gclid=CjwKCAjwhJukBhBPEiwAniIcNcPpvaGlbKHuP7YC9bsc-F9R6vUM1bUzfp0VyZwfI_pwZ_6Bk_P2jhoCORwQAvD_BwE
Healthcare delivery - https://troymedia.com/politicslaw/danielle-smiths-first-challenge-will-be-to-fix-alberta-healthcare/
Optimization of healthcare - https://www.wolterskluwer.com/en/expert-insights/the-importance-of-the-optimal-nursetopatient-ratio or https://www.slideshare.net/paulyoungcga/how-to-fix-the-healthcare-delivery-model-around-the-globepptx
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - July 2023....paul young cpa, cga
The global market for pharmaceuticals reached USD 1.25 trillion in 2019, up 4.5% from 2018. Going forward, the global market will grow by 4-5% CAGR, reaching USD 1.5 trillion by 2023.
North America is expected to retain the leading position in the global pharmaceuticals market with market share of 45.33% in.
Source - https://www.reogma.com/industry-reports/global-pharmaceutical-industry-to-reach-1-5-trillion-by-2023/
Key links and sources:
Generative AI and Healthcare - https://www.statnews.com/2023/07/18/medical-ai-doctors-chatgpt/?utm_campaign=rss
Patents - https://www.pharmaceutical-technology.com/news/patents-signal-china-leads-with-patent-filings-in-pharma-in-q2/
Biotech - https://www.investors.com/news/technology/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead/
Trends - https://blog.gitnux.com/life-science-industry-trends/
Biotech upcoming companies - https://www.fool.com/investing/2023/07/17/this-artificial-intelligence-biotech-stock-is-crus/
ESG - https://www.mltaikins.com/esg/global-climate-litigation-continues-to-heat-up-highlighting-esg-risks/
ESG - https://invivo.pharmaintelligence.informa.com/IV147763/Pressure-Mounts-On-Pharma-To-Act-On-Environmental-Targets
Canada has a strong biotech and pharmaceutical manufacturing sector, with five major vaccine producers operating facilities in the country as of 2009. However, Justin Trudeau has not taken adequate steps to support domestic production of vaccines and critical supply chain items. While AI and data analytics show promise for driving innovation in areas like drug discovery and supply chain management, Canada risks losing opportunities without policies that encourage reshoring of manufacturing and investment in emerging technologies.
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - September ...paul young cpa, cga
This document provides an overview and agenda for a presentation on the biotech, pharmaceutical, and healthcare sector. It includes:
- An introduction and biography of presenter Paul Young CPA CGA
- An agenda covering topics like vaccine production, drug discovery, innovation in areas like storage and AI, and the life sciences strategy
- Links and summaries of information on these topics, including the top vaccine manufacturers, regulations in Canada, and growth in the pharmaceutical market
The presentation aims to discuss key areas of the biotech/pharmaceutical sector including vaccine development and production, drug discovery, innovation, and strategies for the life sciences industry. Links and outside sources are provided to support the topics in the agenda.
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - May 2023.pptxpaul young cpa, cga
Blog – Pharmaceutical Biotech Medical Supplies and Equipment – Analysis – May 2023
Summary:
Healthcare, pharma, and biotech continue to look at how best to deploy data and AI as part of their various product lifecycles.
Healthcare continues to look at ways to automate various operational aspects. The key will be how to secure, store, and ingest the data as part of improving patient outcome.
EMEA counties to move forward with key policy changes like DORA, CRA, and ESG reporting.
Biotech^J Pharmaceutical^J and Healthcare Sector - March 2023.pptxpaul young cpa, cga
Blog – Healthcare and Pharmaceutical Sector Analysis – March 2023
Summary
Healthcare systems around the world continue to face many challenges
Additional sources:
AI and the pharmaceutical sector - https://www.linkedin.com/pulse/ai-pharmaceutical-market-giants-spending-going-boom-abbvie-pimpalkar/
AI and Automation - https://accelerationeconomy.com/ai/how-ai-and-automation-enhance-healthcare-from-medical-diagnosis-to-supply-chains/
Continue support of health and wellness programs as part of managing the overall healthcare sector is key area as part of improving patient outcomes. https://www.globenewswire.com/en/news-release/2023/03/31/2638434/0/en/Nurturing-a-Healthier-World-The-Health-and-Wellness-Market-Scaling-New-Heights-Driven-by-Growing-Demand-for-Sustainable-and-Natural-Products.html
Automating the care management model will be key to delivering better healthcare outcomes - https://www.globenewswire.com/news-release/2023/03/30/2637293/0/en/Care-Management-Market-Is-Expected-to-Reach-USD-33-3-Billion-by-2030-Grow-at-a-CAGR-Of-14-41-during-Forecast-Period-2023-To-2030-Data-By-Contrive-Datum-Insights-Pvt-Ltd.html
Managing healthcare costs as part of delivering better patient outcomes has been a challenge for governments around the world - https://www.kff.org/health-costs/issue-brief/how-does-medical-inflation-compare-to-inflation-in-the-rest-of-the-economy/
Adopting a digital model continues to be challenge for healthcare providers - https://techupforwomen.com/qa-cost-is-the-most-significant-barrier-to-digital-health-adoption/
Healthcare continues to look at ways to adopt technology - https://www.odgersinterim.com/us/who-we-are/intelligence/the-power-of-technology-to-transform-healthcare-5174/ and https://www.jabil.com/blog/connected-health-technology-trends.html
Synthetic data and healthcare - https://mostly.ai/blog/healthcare-data-platform/
Data and AI - https://www.healthcareitnews.com/news/data-analytics-platform-and-integrated-tools
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - June 2023....paul young cpa, cga
Blog – Pharma Healthcare and Biotech – Commentary and Analysis – June 2023
1. Limited market understanding
2. Regulatory compliance
3. Limited marketing budget
4. Long sales cycle
5. Communication of Scientific Complexity
Source - https://www.linkedin.com/pulse/navigating-marketing-challenges-biotech-industry-solutions-satya/
Additional sources and links:
ESG and Sustainability - https://www.hospitalmanagement.net/dashboards/filings/environmental-sustainability-mentions-healthcare-industry/ or https://www.pharmaceutical-technology.com/sponsored/the-rise-and-rise-of-esg-in-the-pharmaceutical-sector-is-a-zero-waste-supply-chain-possible/ or
Trusted AI - https://www.csis.org/analysis/path-trustworthy-ai-g7-outcomes-and-implications-global-ai-governance
Drug costs - https://www.healthaffairs.org/content/forefront/medicare-drug-price-negotiation-few-drugs-big-impact
Patents - https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-pfizer-hit-with-new-patent-lawsuits-over-covid-vaccines-2023-06-06/
Globalization - https://www.rbcwealthmanagement.com/en-asia/insights/worlds-apart-risks-and-opportunities-as-deglobalization-looms
Healthcare - https://www.globsec.org/what-we-do/commentaries/bridging-healthcare-gap-solidarity-and-investment-east-west-equality
Medical top technologies - https://healthnews.com/family-health/healthy-living/wearable-medical-devices-used-in-healthcare/ or
Challenges - https://www.nasdaq.com/articles/3-key-biotech-trends-for-2023-and-beyond
Digital - https://www.valtech.com/industries/health/?utm_content=linkedin_retargeting&gclid=CjwKCAjwhJukBhBPEiwAniIcNcPpvaGlbKHuP7YC9bsc-F9R6vUM1bUzfp0VyZwfI_pwZ_6Bk_P2jhoCORwQAvD_BwE
Healthcare delivery - https://troymedia.com/politicslaw/danielle-smiths-first-challenge-will-be-to-fix-alberta-healthcare/
Optimization of healthcare - https://www.wolterskluwer.com/en/expert-insights/the-importance-of-the-optimal-nursetopatient-ratio or https://www.slideshare.net/paulyoungcga/how-to-fix-the-healthcare-delivery-model-around-the-globepptx
Biotech Pharmaceutical Medical Equipment and Supplies - Analysis - July 2023....paul young cpa, cga
The global market for pharmaceuticals reached USD 1.25 trillion in 2019, up 4.5% from 2018. Going forward, the global market will grow by 4-5% CAGR, reaching USD 1.5 trillion by 2023.
North America is expected to retain the leading position in the global pharmaceuticals market with market share of 45.33% in.
Source - https://www.reogma.com/industry-reports/global-pharmaceutical-industry-to-reach-1-5-trillion-by-2023/
Key links and sources:
Generative AI and Healthcare - https://www.statnews.com/2023/07/18/medical-ai-doctors-chatgpt/?utm_campaign=rss
Patents - https://www.pharmaceutical-technology.com/news/patents-signal-china-leads-with-patent-filings-in-pharma-in-q2/
Biotech - https://www.investors.com/news/technology/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead/
Trends - https://blog.gitnux.com/life-science-industry-trends/
Biotech upcoming companies - https://www.fool.com/investing/2023/07/17/this-artificial-intelligence-biotech-stock-is-crus/
ESG - https://www.mltaikins.com/esg/global-climate-litigation-continues-to-heat-up-highlighting-esg-risks/
ESG - https://invivo.pharmaintelligence.informa.com/IV147763/Pressure-Mounts-On-Pharma-To-Act-On-Environmental-Targets
Canada has a strong biotech and pharmaceutical manufacturing sector, with five major vaccine producers operating facilities in the country as of 2009. However, Justin Trudeau has not taken adequate steps to support domestic production of vaccines and critical supply chain items. While AI and data analytics show promise for driving innovation in areas like drug discovery and supply chain management, Canada risks losing opportunities without policies that encourage reshoring of manufacturing and investment in emerging technologies.
- Canada has had 5 vaccine manufacturing plants since 2009, but Trudeau has not been honest about issues with domestic production. A 2016 report by Biotech Canada outlined Canada's vaccine production landscape.
- While Canada's biotech industry has been strong for decades, Trudeau's policies have not focused on bringing production back to Canada and have contributed to an exodus of foreign direct investment.
- Trudeau has been health minister for over 5 years but has done little to modernize healthcare systems or prepare for domestic vaccine manufacturing challenges that were known well in advance of the pandemic.
The document provides an overview of the current Canadian vaccine environment, including:
1) The global and Canadian vaccine markets, which are growing significantly but still represent a small portion of pharmaceutical markets.
2) The complex process required for introducing new vaccines, which involves regulatory approval, funding, recommendations, and infrastructure.
3) The key players in Canada's vaccine system, including manufacturers, government agencies, medical societies, and others.
4) Recommendations to improve Canada's vaccine system by recognizing its value, encouraging investment, streamlining processes, and ensuring resources for programs and surveillance.
Paul Young provides a summary of the global race to develop COVID-19 vaccines and testing. He profiles several key companies involved including CanSino Biologics, Symvivo Corporation, Novovax, CureVac, Generex, Vaxart, and Medicago. Many of these companies have received funding from governments and organizations like the Bill & Melinda Gates Foundation to accelerate vaccine development. The document also discusses testing kits, treatments, and the efforts of government and health organizations in monitoring the pandemic.
Paul Young provides a summary of the global race to develop COVID-19 vaccines and testing. He profiles 13 companies working on vaccines, including CanSino, Symvivo, Novavax, CureVac, and Medicago. These companies are at different stages, with some already in clinical trials. Funding is coming from various sources including governments, coalitions, and private investors. The document also discusses testing kits, treatments, and the roles of various organizations in addressing the pandemic.
How best to Management a Pandemic| Geopolitical Event| November 25, 2020 paul young cpa, cga
This document provides an overview and update on the global race to develop vaccines and testing for COVID-19. It profiles over a dozen companies and organizations working on vaccines or testing, including CanSino, Novavax, CureVac, Medicago, and Altimmune. The document also discusses treatment options like antibodies and convalescent plasma. Testing kits can cost around $129 per person and the global testing market is projected to reach $44 billion in 2020. While vaccines are progressing in trials, antibodies from prior infection may only provide short-term immunity. Continued preventative measures are still encouraged.
COVID19| Race to Vaccine and Expediting Testing| June 2020paul young cpa, cga
This document provides an overview of the global race to develop a COVID-19 vaccine and testing capabilities. It profiles several pharmaceutical and biotech companies working on vaccine candidates, including CanSino, Symvivo, Novavax, CureVac, Generex, Vaxart, Medicago, Takis, and Altimmune. It also discusses testing kits, global testing capacity, and partnerships to support vaccine development efforts. Major players like the Coalition for Epidemic Preparedness Innovations are funding many of these companies to accelerate clinical trials and manufacturing.
Paul Young presented information on the global race to develop a COVID-19 vaccine and testing. Several companies were highlighted including CanSino, Symvivo, Novavax, CureVac, Generex, and Vaxart that are developing vaccine candidates using various technologies. Updates were provided on vaccine development by companies like GSK, Moderna, and partnerships involving the Gates Foundation. Information was also presented on testing including new rapid tests in development and the high costs associated with global testing.
The world faced unprecedented challenges when it came to COVID19 viruses. The world is still working through COVID19 including testing, vaccines, reopening of the economy, and contact tracing
This document provides an overview and updates on the global race to develop vaccines and testing for COVID-19. It profiles several key companies involved in vaccine development, including CanSino Biologics, Symvivo Corporation, Novavax, CureVac, Generex, Vaxart, Medicago, and Altimmune. It also discusses companies involved in testing, treatment options like antibodies, and global testing market trends. Major funding sources like the Bill and Melinda Gates Foundation and governments are supporting many of these efforts. Additional research is still needed but progress is being made on vaccines, testing, and treatments.
- Many pharmaceutical companies and research institutions are racing to develop a COVID-19 vaccine. Key players discussed include CanSino, Novavax, CureVac, and Moderna.
- Testing is also a major focus. Rapid at-home testing kits that provide results within 10 minutes are in development. The global COVID testing market is expected to reach $44 billion in 2020.
- Potential treatment options discussed include convalescent plasma from recovered patients and further research on antibodies and the human genome to better understand risk factors and immunity. However, antibody levels appear to decrease significantly within 2-3 months.
- Many pharmaceutical companies and research institutions around the world are racing to develop a vaccine for COVID-19. Some of the leading candidates include vaccines in development by CanSino, Novavax, CureVac, and Moderna.
- Testing is also ramping up globally to identify cases and track the spread of the virus. Rapid at-home test kits that provide results within 10 minutes are in development.
- Treatments under investigation include convalescent plasma from recovered patients, as antibodies may provide some protection. However, research shows antibody levels start declining within 2-3 months.
Geopolitical Events| Vaccines Distribution| Canada| April 3, 2021paul young cpa, cga
This document provides an overview and analysis of geopolitical events and vaccine rollouts for the week ending April 2, 2021. It includes data on COVID-19 cases, deaths, and vaccinations by country. It also discusses employment rates, GDP forecasts, supply chain issues, and recommendations for managing risks going forward, with a focus on opening economies safely, auditing crisis management policies, and supporting the private sector through government cooperation.
How to fix the Healthcare Delivery Model around the Globe.pptxpaul young cpa, cga
Blog – How to address issues with the Healthcare Delivery Model – Canada and the World
Healthcare continues to be one of the largest expenses for provinces and territories across Canada - https://nationalpost.com/news/politics/health-care-funding-deadlocked-as-trudeau-says-provinces-wont-get-more-money-without-system-reforms
Healthcare needs to move to homecare model as part of managing beds across the healthcare system - https://www.marketwatch.com/press-release/home-care-services-market-size-in-global-survey-2023-with-risk-analysis-by-company-profiles-forecast-timeframe-2026-2022-12-12
Digital healthcare needs to be embrace by all levels of government as part of managing healthcare including improving outcomes - https://www.mckinsey.com/industries/life-sciences/our-insights/german-e-health-offerings-expand-but-adoption-remains-uneven
Technology continues to evolve with healthcare. More needs to be done to embrace technology as part of improving patient outcomes. https://www.forbes.com/sites/forbesbusinesscouncil/2022/12/09/future-of-health-top-five-digital-health-innovations-for-2023/?sh=21184fab1e5e or https://www.beckershospitalreview.com/innovation/the-top-innovation-trends-of-2022-according-to-health-system-execs.html
Health and wellness programs need to be expanded through tax credits and other policy changes - https://www.shopify.com/ca/enterprise/health-wellness-trends
More needs to be done to address seniors living in poverty including adjusting GIS to a new threshold of 40K - https://www.springfinancial.ca/blog/boost-your-income/guaranteed-income-supplement-gis
More needs to be done with hiring practices of healthcare professional including expanding the nurses, doctors, and other healthcare spots at colleges and universities - https://www.immigration.ca/canadas-lack-of-residencies-for-foreign-trained-doctors-fuelling-healthcare-labour-shortage/
Pharma and drug companies need to work with all levels of government to curb the high costs of drugs - https://www.slideshare.net/secret/iXrYNeBocHT51
Opening spots for more assisted living needs to forge ahead - https://www.slideshare.net/paulyoungcga/policy-analysis-seniors-assisted-living-and-longterm-carepptx
Healthcare needs to look at privatization options as part of managing the delivery healthcare to patients https://www.expatriatehealthcare.com/the-top-10-healthcare-systems-in-the-world-2022/
How Best to Managed a Pandemic| Crisis Management| December 22, 2020paul young cpa, cga
This document provides an overview and updates on the global race to develop vaccines and testing for COVID-19. It profiles over a dozen pharmaceutical companies and research organizations working on vaccine development, including CanSino, Novavax, CureVac, and Moderna. It also discusses the development of testing kits and options for treating COVID-19 such as antibodies and public health interventions. The document analyzes financing, clinical trials, production challenges and geopolitical factors shaping the pandemic response.
This document provides an overview and updates on the global race to develop vaccines and treatments for COVID-19. It profiles over a dozen companies and organizations working on vaccine development, including CanSino, Novavax, CureVac, and Moderna. The document also discusses testing efforts and options for treatment, such as antibodies and mitigation strategies. Major players like the WHO, CDC, and governments are monitoring the situation and impacts on healthcare systems, economies, and case/death counts.
Israel still leads the world in terms of vaccinations - https://ourworldindata.org/covid-vaccinations
There have been issues with PCR testing - https://theorca.ca/visiting-pod/failure-to-use-rapid-tests-points-to-deeper-problems/ or All testing needs to be done in relations with other tests - https://www.politifact.com/factchecks/2021/jan/22/gateway-pundit/who-did-not-admit-pcr-tests-grossly-inflate-positi/
Global economy will have a long road to recovery - https://www2.deloitte.com/us/en/insights/economy/global-economic-outlook/weekly-update.html/
Global Risks - https://www.youtube.com/watch?v=83rTDoqdCtY
Poverty - https://www.thehindu.com/news/international/oxfam-urges-radical-economic-rejig-for-post-covid-world/article33655102.ece
Retail Sales and Consumer Spending Analysis and Commentary - July 2023.pptxpaul young cpa, cga
Canadian retail sales dropped 0.3% in August, the first decline since March, as higher interest rates start to impact household budgets. Seven of the nine retail subsectors saw sales increases in July, led by food and beverage retailers, while motor vehicle and parts dealers saw the largest decrease. Excluding autos, retail sales in July rose 1%, double expectations. The report suggests Canadians are tightening spending as more face higher mortgage payments and gas prices due to Bank of Canada rate hikes aimed at slowing inflation.
Addressing issues with the Public Sector Governance Model.pptxpaul young cpa, cga
The key challenges facing Australian business leaders in 2023 include:
1. Talent acquisition, retention and training staff for digital transformation.
2. Implementing successful digital transformation while managing cyber risks.
3. Adapting to changing regulations and reporting requirements.
Health risks from COVID-19, social reputation concerns, and disruptive emerging technologies are also significant social challenges impacting Australian businesses. Over the next 3-5 years, talent management for digitization, cybersecurity, digital transformation, regulatory changes, and identifying new growth opportunities will be the top challenges according to business leaders.
- Canada has had 5 vaccine manufacturing plants since 2009, but Trudeau has not been honest about issues with domestic production. A 2016 report by Biotech Canada outlined Canada's vaccine production landscape.
- While Canada's biotech industry has been strong for decades, Trudeau's policies have not focused on bringing production back to Canada and have contributed to an exodus of foreign direct investment.
- Trudeau has been health minister for over 5 years but has done little to modernize healthcare systems or prepare for domestic vaccine manufacturing challenges that were known well in advance of the pandemic.
The document provides an overview of the current Canadian vaccine environment, including:
1) The global and Canadian vaccine markets, which are growing significantly but still represent a small portion of pharmaceutical markets.
2) The complex process required for introducing new vaccines, which involves regulatory approval, funding, recommendations, and infrastructure.
3) The key players in Canada's vaccine system, including manufacturers, government agencies, medical societies, and others.
4) Recommendations to improve Canada's vaccine system by recognizing its value, encouraging investment, streamlining processes, and ensuring resources for programs and surveillance.
Paul Young provides a summary of the global race to develop COVID-19 vaccines and testing. He profiles several key companies involved including CanSino Biologics, Symvivo Corporation, Novovax, CureVac, Generex, Vaxart, and Medicago. Many of these companies have received funding from governments and organizations like the Bill & Melinda Gates Foundation to accelerate vaccine development. The document also discusses testing kits, treatments, and the efforts of government and health organizations in monitoring the pandemic.
Paul Young provides a summary of the global race to develop COVID-19 vaccines and testing. He profiles 13 companies working on vaccines, including CanSino, Symvivo, Novavax, CureVac, and Medicago. These companies are at different stages, with some already in clinical trials. Funding is coming from various sources including governments, coalitions, and private investors. The document also discusses testing kits, treatments, and the roles of various organizations in addressing the pandemic.
How best to Management a Pandemic| Geopolitical Event| November 25, 2020 paul young cpa, cga
This document provides an overview and update on the global race to develop vaccines and testing for COVID-19. It profiles over a dozen companies and organizations working on vaccines or testing, including CanSino, Novavax, CureVac, Medicago, and Altimmune. The document also discusses treatment options like antibodies and convalescent plasma. Testing kits can cost around $129 per person and the global testing market is projected to reach $44 billion in 2020. While vaccines are progressing in trials, antibodies from prior infection may only provide short-term immunity. Continued preventative measures are still encouraged.
COVID19| Race to Vaccine and Expediting Testing| June 2020paul young cpa, cga
This document provides an overview of the global race to develop a COVID-19 vaccine and testing capabilities. It profiles several pharmaceutical and biotech companies working on vaccine candidates, including CanSino, Symvivo, Novavax, CureVac, Generex, Vaxart, Medicago, Takis, and Altimmune. It also discusses testing kits, global testing capacity, and partnerships to support vaccine development efforts. Major players like the Coalition for Epidemic Preparedness Innovations are funding many of these companies to accelerate clinical trials and manufacturing.
Paul Young presented information on the global race to develop a COVID-19 vaccine and testing. Several companies were highlighted including CanSino, Symvivo, Novavax, CureVac, Generex, and Vaxart that are developing vaccine candidates using various technologies. Updates were provided on vaccine development by companies like GSK, Moderna, and partnerships involving the Gates Foundation. Information was also presented on testing including new rapid tests in development and the high costs associated with global testing.
The world faced unprecedented challenges when it came to COVID19 viruses. The world is still working through COVID19 including testing, vaccines, reopening of the economy, and contact tracing
This document provides an overview and updates on the global race to develop vaccines and testing for COVID-19. It profiles several key companies involved in vaccine development, including CanSino Biologics, Symvivo Corporation, Novavax, CureVac, Generex, Vaxart, Medicago, and Altimmune. It also discusses companies involved in testing, treatment options like antibodies, and global testing market trends. Major funding sources like the Bill and Melinda Gates Foundation and governments are supporting many of these efforts. Additional research is still needed but progress is being made on vaccines, testing, and treatments.
- Many pharmaceutical companies and research institutions are racing to develop a COVID-19 vaccine. Key players discussed include CanSino, Novavax, CureVac, and Moderna.
- Testing is also a major focus. Rapid at-home testing kits that provide results within 10 minutes are in development. The global COVID testing market is expected to reach $44 billion in 2020.
- Potential treatment options discussed include convalescent plasma from recovered patients and further research on antibodies and the human genome to better understand risk factors and immunity. However, antibody levels appear to decrease significantly within 2-3 months.
- Many pharmaceutical companies and research institutions around the world are racing to develop a vaccine for COVID-19. Some of the leading candidates include vaccines in development by CanSino, Novavax, CureVac, and Moderna.
- Testing is also ramping up globally to identify cases and track the spread of the virus. Rapid at-home test kits that provide results within 10 minutes are in development.
- Treatments under investigation include convalescent plasma from recovered patients, as antibodies may provide some protection. However, research shows antibody levels start declining within 2-3 months.
Geopolitical Events| Vaccines Distribution| Canada| April 3, 2021paul young cpa, cga
This document provides an overview and analysis of geopolitical events and vaccine rollouts for the week ending April 2, 2021. It includes data on COVID-19 cases, deaths, and vaccinations by country. It also discusses employment rates, GDP forecasts, supply chain issues, and recommendations for managing risks going forward, with a focus on opening economies safely, auditing crisis management policies, and supporting the private sector through government cooperation.
How to fix the Healthcare Delivery Model around the Globe.pptxpaul young cpa, cga
Blog – How to address issues with the Healthcare Delivery Model – Canada and the World
Healthcare continues to be one of the largest expenses for provinces and territories across Canada - https://nationalpost.com/news/politics/health-care-funding-deadlocked-as-trudeau-says-provinces-wont-get-more-money-without-system-reforms
Healthcare needs to move to homecare model as part of managing beds across the healthcare system - https://www.marketwatch.com/press-release/home-care-services-market-size-in-global-survey-2023-with-risk-analysis-by-company-profiles-forecast-timeframe-2026-2022-12-12
Digital healthcare needs to be embrace by all levels of government as part of managing healthcare including improving outcomes - https://www.mckinsey.com/industries/life-sciences/our-insights/german-e-health-offerings-expand-but-adoption-remains-uneven
Technology continues to evolve with healthcare. More needs to be done to embrace technology as part of improving patient outcomes. https://www.forbes.com/sites/forbesbusinesscouncil/2022/12/09/future-of-health-top-five-digital-health-innovations-for-2023/?sh=21184fab1e5e or https://www.beckershospitalreview.com/innovation/the-top-innovation-trends-of-2022-according-to-health-system-execs.html
Health and wellness programs need to be expanded through tax credits and other policy changes - https://www.shopify.com/ca/enterprise/health-wellness-trends
More needs to be done to address seniors living in poverty including adjusting GIS to a new threshold of 40K - https://www.springfinancial.ca/blog/boost-your-income/guaranteed-income-supplement-gis
More needs to be done with hiring practices of healthcare professional including expanding the nurses, doctors, and other healthcare spots at colleges and universities - https://www.immigration.ca/canadas-lack-of-residencies-for-foreign-trained-doctors-fuelling-healthcare-labour-shortage/
Pharma and drug companies need to work with all levels of government to curb the high costs of drugs - https://www.slideshare.net/secret/iXrYNeBocHT51
Opening spots for more assisted living needs to forge ahead - https://www.slideshare.net/paulyoungcga/policy-analysis-seniors-assisted-living-and-longterm-carepptx
Healthcare needs to look at privatization options as part of managing the delivery healthcare to patients https://www.expatriatehealthcare.com/the-top-10-healthcare-systems-in-the-world-2022/
How Best to Managed a Pandemic| Crisis Management| December 22, 2020paul young cpa, cga
This document provides an overview and updates on the global race to develop vaccines and testing for COVID-19. It profiles over a dozen pharmaceutical companies and research organizations working on vaccine development, including CanSino, Novavax, CureVac, and Moderna. It also discusses the development of testing kits and options for treating COVID-19 such as antibodies and public health interventions. The document analyzes financing, clinical trials, production challenges and geopolitical factors shaping the pandemic response.
This document provides an overview and updates on the global race to develop vaccines and treatments for COVID-19. It profiles over a dozen companies and organizations working on vaccine development, including CanSino, Novavax, CureVac, and Moderna. The document also discusses testing efforts and options for treatment, such as antibodies and mitigation strategies. Major players like the WHO, CDC, and governments are monitoring the situation and impacts on healthcare systems, economies, and case/death counts.
Israel still leads the world in terms of vaccinations - https://ourworldindata.org/covid-vaccinations
There have been issues with PCR testing - https://theorca.ca/visiting-pod/failure-to-use-rapid-tests-points-to-deeper-problems/ or All testing needs to be done in relations with other tests - https://www.politifact.com/factchecks/2021/jan/22/gateway-pundit/who-did-not-admit-pcr-tests-grossly-inflate-positi/
Global economy will have a long road to recovery - https://www2.deloitte.com/us/en/insights/economy/global-economic-outlook/weekly-update.html/
Global Risks - https://www.youtube.com/watch?v=83rTDoqdCtY
Poverty - https://www.thehindu.com/news/international/oxfam-urges-radical-economic-rejig-for-post-covid-world/article33655102.ece
Retail Sales and Consumer Spending Analysis and Commentary - July 2023.pptxpaul young cpa, cga
Canadian retail sales dropped 0.3% in August, the first decline since March, as higher interest rates start to impact household budgets. Seven of the nine retail subsectors saw sales increases in July, led by food and beverage retailers, while motor vehicle and parts dealers saw the largest decrease. Excluding autos, retail sales in July rose 1%, double expectations. The report suggests Canadians are tightening spending as more face higher mortgage payments and gas prices due to Bank of Canada rate hikes aimed at slowing inflation.
Addressing issues with the Public Sector Governance Model.pptxpaul young cpa, cga
The key challenges facing Australian business leaders in 2023 include:
1. Talent acquisition, retention and training staff for digital transformation.
2. Implementing successful digital transformation while managing cyber risks.
3. Adapting to changing regulations and reporting requirements.
Health risks from COVID-19, social reputation concerns, and disruptive emerging technologies are also significant social challenges impacting Australian businesses. Over the next 3-5 years, talent management for digitization, cybersecurity, digital transformation, regulatory changes, and identifying new growth opportunities will be the top challenges according to business leaders.
Global Housing Market Analysis and Commentary- September 2023.pptxpaul young cpa, cga
Summary:
Homebuilders are walking a fine line when it comes to new projects as high mortgage rates curb demand.
New residential construction, including single-family homes and multifamily, dropped 11.3% month over month in August to 1.283 million units on a seasonally adjusted basis, according to Census Bureau data released Tuesday. That's down 14.8% compared with a year ago and well below the 1.44 million units economists surveyed by Bloomberg projected.
But authorized residential permits — an indicator of potential future activity — rose 6.9% to 1.543 million permits in August from July. That was still down 2.7% from last August. Single-family permits, though, were up 2% from July to 949,000. Multifamily permits came in at 535,000.
The data reflects two opposing forces builders are trying to balance: the ongoing need for new construction to fill in limited inventory and elevated mortgage rates that are hurting their biggest customer right now, the first-time homebuyer.
"High mortgage rates are clearly taking a toll on builder confidence and consumer demand, as a growing number of buyers are electing to defer a home purchase until long-term rates move lower," Robert Dietz, chief economist of the National Association of Home Builders, said Monday in a press release after builder confidence dropped for the second straight month.
Source: https://ca.finance.yahoo.com/news/homebuilders-face-a-tough-balancing-act-on-new-construction-amid-high-mortgage-rates-130744368.html
Blog – What is next for the Mining Sector – September 2023
The mining sector provides critical material that support solar, wind, and lithium-ion batteries as part of the green transition. https://www.iea.org/news/critical-minerals-market-sees-unprecedented-growth-as-clean-energy-demand-drives-strong-increase-in-investment
The mining sector products play a key role with the global GDP - https://www.yicaiglobal.com/news/global-mining-industry-value-was-69-of-world-gdp-last-year-china-says
Mining practices need to be sustainable including following all ESG policies - https://www.linkedin.com/advice/1/how-can-you-monitor-sustainable-mining-practices
Other links and sources –
Lithium Supply and Price - https://zbr.com.mx/en/sin-categoria-es/lithium-prices-fall-44-in-china-due-to-lack-of-demand/138168/
Cobalt - https://www.linkedin.com/posts/mahmut-karada%C5%9F-a2b7a5151_china-exportrestrictions-gallium-activity-7082603182589157376-Zrty/?trk=public_profile_like_view
Nickel https://www.eureporter.co/business/2023/09/15/stanislav-kondrashov-from-telf-ag-nickel-prices-outlook-remains-positive/
Iron-ore - https://www.brecorder.com/news/40263584/sgx-iron-ore-set-for-best-week-in-3-months
TD Bank / Metals - https://www.tdsecurities.com/ca/en/setting-the-stage-for-gold-outlook
Biodiversity / Mining - https://worldcrunch.com/green/lithium-green-energy-argentina-indigenous
ESG - https://iriscarbon.com/the-added-value-of-integrated-esg-reporting-a-threefold-framework/
Blog – Manufacturing Shipments and Orders – The United States – August 2023
Summary:
New orders for manufacturing technology in the United States totaled $353.9 million in July 2023, as per the latest report by AMT – The Association For Manufacturing Technology. This figure marked a 12.4% decline from June 2023 but remained only 10.5% lower than July 2022. Year-to-date orders amounted to $2.83 billion, reflecting a 12.7% decrease compared to the same period the previous year.
Douglas K. Woods, President of AMT, noted that July is typically a slower month for manufacturing technology orders, so a slight drop was expected. However, he pointed out a notable trend: over the last two months, the year-to-date order gap has narrowed during historically slow periods. While job shops have seen decreased orders, other industries that benefited from reshoring or government investments have helped fill the gap.
Among specific sectors, job shops, the largest customer segment, placed their lowest total monthly orders since August 2020. In contrast, metal valve manufacturers recorded their third-highest monthly order value on record, last seen in September 2018, making up nearly 5% of the total manufacturing technology order value for July 2023. Manufacturers of motor vehicle transmissions continued to order machinery at an elevated pace. However, the aerospace industry continued to order below its early 2022 peaks, with hopes that recent projects like the federal government's $1.5 billion investment in communications satellites might reverse this trend.
Source: https://www.sme.org/technologies/articles/2023/september/u.s.-manufacturing-technology-orders-dip-in-july-but-show-resilience-amid-economic-uncertainty
Stock Market Analysis and Commentary for WE September 15 2023.pptxpaul young cpa, cga
Blog – Analysis and Commentary – Stock Market – WE September 15 2023
Summary:
Stocks fell Friday as investors wrap up a volatile week ahead of the Federal Reserve's policy meeting.
The Dow Jones Industrials tumbled 288.87 points to close out Friday and the week at 34,618.24. At its lows, it completely wiped out Thursday's 332-point rally.
The S&P 500 index sank 54.78 points, or 1.2%, to 4,450.32.
The NASDAQ index plunged 217.72 points, or 1.6%, to 13,708.33.
The Dow held onto a winning week. The S&P 500 and NASDAQ both closed out the week with losses.
Information technology was the worst-performing sector in the S&P 500, down nearly 2%. Adobe shares fell more than 4% even after the software firm posted better-than-expected quarterly results. Shares of Arm Holdings were lower one day after its successful public debut.
Auto stocks General Motors and Stellantis N.V. were higher Friday, while Ford Motor was about flat. Thousands of members of the United Auto Workers went on strike after failing to reach a deal with the automakers Thursday night.
Elsewhere, Lennar shares slid 3%. The home construction firm posted third-quarter results that beat on the top and bottom lines.
On the economic front, the University of Michigan's consumer sentiment survey showed one-year inflation expectations dropped to 3.1% in
September, tied for the lowest since January 2021. Also, the five-year outlook fell to 2.7%, matching its lowest since December 2020.
- Canadian manufacturing sales increased 1.6% in July, led by higher sales in food products, petroleum and coal products, and transportation equipment. Paper and plastics sales decreased the most.
- Inventory levels increased slightly while unfilled orders decreased, pointing to a potential slowdown.
- The manufacturing sector in Canada will continue to face challenges such as global economic uncertainty, rising costs, supply chain issues, climate change risks, and skills shortages.
Electricity Analysis - Canada and the OECD - June 2023.pptxpaul young cpa, cga
Summary:
Over three-quarters of the world’s total coal-generated electricity is consumed in just three countries. China is the top user of coal, making up 53.3% of global coal demand, followed by India at 13.6%, and the U.S. at 8.9%.
Burning coal—for electricity, as well as metallurgy and cement production—is the world’s single largest source of CO2 emissions. Nevertheless, its use in electricity generation has actually grown 91.2% since 1997, the year when the first global climate agreement was signed in Kyoto, Japan.
However, even as non-renewables enjoy their time in the sun, their days could be numbered.
In 2022, renewables, such as wind, solar, and geothermal, represented 14.4% of total electricity generation with an extraordinary annual growth rate of 14.7%, driven by big gains in solar and wind. Non-renewables, by contrast, only managed an anemic 0.4%.
The authors of the Statistical Review do not include hydroelectric in their renewable calculations, even though many others, including the International Energy Agency, consider it a “well-established renewable power technology.”
With hydroelectric moved into the renewable column, together they accounted for over 29.3% of all electricity generated in 2022, with an annual growth rate of 7.4%.
Source - https://energynow.ca/2023/09/infographic-what-electricity-sources-power-the-world-see-them-here-visual-capitalist/
Logistics Warehousing Transportation and Distrbution Analysis and Commentary ...paul young cpa, cga
The document provides an overview of key metrics and trends in the logistics, warehousing, distribution, and transportation sector. It includes data on consumer price index, diesel fuel costs, freight indexes, e-commerce sales, retail sales, class 8 truck sales, EPA emissions standards, trailer sales, and tonnage. It also discusses supply chain management solutions like planning analytics, blockchain, and AI assistants. Finally, it touches on topics like infrastructure spending, automation, and ESG reporting.
Retail Sales and Consumer Spending Analysis and Commentary - United States - ...paul young cpa, cga
United States retail sales rose 0.6% in August despite flat sales at internet retailers after Amazon Prime Day. Most of the increase was due to higher gasoline prices. While consumer spending has been strong, higher interest rates and a slowdown in hiring are expected to restrain purchases in the coming months. Forecasters predict the 2023 holiday shopping season could be the weakest in five years due to economic challenges facing consumers. The retail sector continues facing inventory management challenges and social governance issues.
How to improve the Governance Model for the Public Sector - United States - S...paul young cpa, cga
This document provides a summary of strategies to improve governance in government. It discusses factors that impact governance like transparency and accountability. It recommends using performance audits to assess key performance indicators and ensure recommendations are implemented. Other strategies include improving data ethics and literacy, mitigating geopolitical risks, adopting ESG reporting, and using technology like audit analytics and AI to enhance governance. The overall goal is for government to deliver programs and tax policies with value for money and transparency.
This document provides an analysis of the agriculture output and equipment sector for August 2023. It includes discussions of commodity prices, crop estimates, energy prices, food prices, farming incomes, top farming states, food processors, and the role of technology and government in farming. Key points covered include rising input costs challenging farmers, preliminary crop estimates for Canada, volatility in oil and diesel prices impacting farm expenses, and opportunities for data and automation to help address issues in the agriculture industry.
Better Public Safety Management using Analytics - September 2023.pptxpaul young cpa, cga
This document discusses using analytics to improve public safety management. It outlines rising public safety costs for governments and key issues facing policing like complex crimes and accountability. The document presents crime rate data for Canada and discusses building machine learning models in SPSS and dashboards in Cognos Analytics to analyze police data and forecast expenses. Finally, it lists potential next steps for crime in Canada like bail and corrections reforms, gun control, and increased police oversight.
Stock Market Analysis and Commentary for WE September 9 2023.pptxpaul young cpa, cga
What did the markets tell us this week?
1. Housing supply and costs continue to plague countries around the world.
2. Gasoline prices are on the rise that puts pressure on central banks ability to hit their core inflation targets.
3. ESG adoption by both the private and public sector is leading to both funding concerns and the overall cost of implementing ESG policies.
4. Adopting technology as part of increasing food production is facing both capital and operational funding concerns.
5. Strike at LNG facility in Australia is leading to concerns around a supply chain disruption of natural gas for EMEA and Asia.
6. The threat of China dumping batteries into markets - https://www.ft.com/content/b6038e51-7b5b-4f97-a5da-9202e71562fc
7. Adoption of generative AI has been facing many challenges related to security, privacy, and ethical issues.
8. Lack of biodiversity planning as part of the overall climate mitigation including sustainable mining, forestry, oil, gas, agriculture, and housing
9. Geopolitical issues continue to impact supply chain.
10. The concerns of recession continue to plague both the private and public sector.
11. Productivity issues continue to plague governments around the world.
Workforce Planning and Employment Analysis - August 2023.pptxpaul young cpa, cga
The document discusses workforce planning and employment analysis. It provides an overview of employment statistics in the United States, Canada, and Australia. It then discusses Sysco's workforce planning model and the role of the CFO in workforce planning. Finally, it defines autonomous finance as the automation of financial operations through software and algorithms, and provides some key statistics on its adoption.
Global Automotive - Analysis and Commentary - August 2023.pptxpaul young cpa, cga
This presentation provides an overview of key trends in the global automotive sector in August 2023. It discusses 1) sales trends in Canada, the US and globally, 2) the growth of electric vehicles and focus on reducing emissions, and 3) ongoing transformation in the industry through automation, connectivity and new technologies. Sources included discuss topics like electric vehicle production and adoption, public safety issues regarding EV fires, gasoline and car prices, supply chain challenges, and green transitions in transportation.
Global (Mining Oil and Gas Forestry and Agriculture) Analysis and Commentary ...paul young cpa, cga
The mining, oil, gas, agriculture, forestry, and mining continue to face environmental, social, and governance policy review including reporting of key metrics as part of ESG reporting cycle.
There is more focus on profitability and investment returns as part of the integrated planning and reporting cycle.
Summary:
The global economy faces what at least one forecaster is calling a mild trade recession as shipments from China slump and German factories downshift.
China’s export declines extended into August, though there were signs that the worst of a world trade slowdown may be over for the leading exporter.
Overseas shipments from China fell 8.8% in dollar terms from a year earlier while imports contracted 7.3%, both better than economists’ estimates and significantly less severe than July’s downturn.
Other data have suggested trade may be stabilizing after weakening for most of this year. Exports from South Korea also declined at a more moderate pace in August than the previous month.
Source: https://www.bloomberg.com/news/newsletters/2023-09-07/supply-chain-latest-world-trade-faces-a-shallow-recession?srnd=economics-v2
Additional sources and links:
Lithium - https://source.benchmarkminerals.com/article/falling-lithium-prices-challenge-potential-cost-advantages-of-sodium-batteries
Oil Production - https://www.cnn.com/2023/09/06/business/oil-price-goldman-sachs/index.html
Natural gas - https://www.fxstreet.com/news/natural-gas-holds-up-as-markets-in-limbo-over-strikes-202309070956
Lumber - https://www.fastmarkets.com/insights/sawmill-capacity-closures-reshape-us-lumber-supply
Critical metals - https://www.wasterecyclingmag.ca/feature/how-recycling-could-solve-the-shortage-of-minerals-essential-to-clean-energy/
Agriculture - https://www.morningagclips.com/economists-forecast-positive-end-of-year-crop-outlook-despite-warmer-midwestern-climate/
ESG - https://www.skadden.com/insights/publications/2023/09/the-informed-board/the-eus-new-esg-disclosure-rules
Ports - https://www.marketscreener.com/quote/stock/HAPAG-LLOYD-AG-24857717/news/Hapag-Lloyd-chief-warns-of-rougher-seas-ahead-for-container-shipping-44789017/
Top destination for reshoring - https://www.thenationalnews.com/business/economy/2023/08/29/uae-in-top-10-most-powerful-passports-for-investment-opportunity/
Global Trade - https://phys.org/news/2023-09-opinion-broke-global-climate-finish.html
What is next for the Forestry Sector and Lumber Production - September 2023.pptxpaul young cpa, cga
Lumber production in Canada continues to face many hurdles
Canada forest management practices are some of the bests in the world
Canada planted over 440M in seedlings back in 2018. It is now 2022 which means close 2M seedlings have been planted.
All levels need to put more focus on urban and rural planning solutions
More work including spending on wildfire and forest fire mitigation
Canada and USA need to find a path forward to resolve the softwood lumber dispute
There needs to a better balanced between climate change policies and growing the economy in a sustainable way
3D printing for housing needs to become mainstream
More protection needs to happen with key ecosystems like wetlands, forest, and peatlands.
There is a risk of debt default if interest rates are hike over the next few months
This document discusses several topics related to education funding and policy in Ontario, Canada. It includes links to articles about the skills gap in trades, teacher salaries, school board budgets, and the Drummond Report which reviewed education spending. The document questions whether the reader looks at school board budgets and supports bringing back ARC analysis of low-enrollment schools. It also debates the impacts of rising construction costs and the carbon tax on education funding.
BONKMILLON Unleashes Its Bonkers Potential on Solana.pdfcoingabbar
Introducing BONKMILLON - The Most Bonkers Meme Coin Yet
Let's be real for a second – the world of meme coins can feel like a bit of a circus at times. Every other day, there's a new token promising to take you "to the moon" or offering some groundbreaking utility that'll change the game forever. But how many of them actually deliver on that hype?
Abhay Bhutada, the Managing Director of Poonawalla Fincorp Limited, is an accomplished leader with over 15 years of experience in commercial and retail lending. A Qualified Chartered Accountant, he has been pivotal in leveraging technology to enhance financial services. Starting his career at Bank of India, he later founded TAB Capital Limited and co-founded Poonawalla Finance Private Limited, emphasizing digital lending. Under his leadership, Poonawalla Fincorp achieved a 'AAA' credit rating, integrating acquisitions and emphasizing corporate governance. Actively involved in industry forums and CSR initiatives, Abhay has been recognized with awards like "Young Entrepreneur of India 2017" and "40 under 40 Most Influential Leader for 2020-21." Personally, he values mindfulness, enjoys gardening, yoga, and sees every day as an opportunity for growth and improvement.
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.
In a tight labour market, job-seekers gain bargaining power and leverage it into greater job quality—at least, that’s the conventional wisdom.
Michael, LMIC Economist, presented findings that reveal a weakened relationship between labour market tightness and job quality indicators following the pandemic. Labour market tightness coincided with growth in real wages for only a portion of workers: those in low-wage jobs requiring little education. Several factors—including labour market composition, worker and employer behaviour, and labour market practices—have contributed to the absence of worker benefits. These will be investigated further in future work.
Independent Study - College of Wooster Research (2023-2024) FDI, Culture, Glo...AntoniaOwensDetwiler
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.
2. PAUL YOUNG - BIO
• CPA, CGA (1996)
• Academia (PF1, FA4, FN2, MU1. and MS2)
• SME – Customer Success Management
• SME – Risk Management
• SME – Close, Consolidate and Reporting
• SME – Public Policy
• SME – Emerging Technology
• SME – Business Process Change
• SME – Financial Solutions
• SME – Macro/Micro Indicators
• SME – Supply Chain Management
• SME – Data, AI, Security, and Platform
• SME – Internal Controls and Auditing
Contact information email: Paul_Young_CGA@hotmail.com
LinkedIn: https://www.linkedin.com/in/paul-young-055632b/
SlideShare - https://www.slideshare.net/paulyoungcga
Twitter: https://twitter.com/paulyoungcpa
Youtube - https://www.youtube.com/user/youngercga1968/videos
3. AGENDA
VACCINE
PRODUCTION
• Drug Discovery/Pharmaceutical Market
• Vaccine Production – Top 10th
• Vaccination Licensing / Production Canada
• DNA sequencing
• Biotech and AI
• Blog – Vaccination and Production
• Life Sciences Strategy
• Breakthroughs with storage and distribution of
vaccines
• Blog - AI-Based imaging analysis tools and cloud-based
deployments to bolster digital pathology market
4. DRUG DISCOVERY AND
PHARMACEUTICAL MARKET
• Outsource drug discovery market - https://www.prnewswire.com/news-releases/global-5-4-billion-drug-
discovery-outsourcing-market-to-2028--301235637.html
• Drug Discovery informatics - https://www.prnewswire.com/news-releases/drug-discovery-informatics-
market-size-worth-5-63-billion-by-2028-grand-view-research-inc-301232269.html
• Pharmaceuticals Market - https://www.globenewswire.com/news-
release/2020/04/27/2022157/0/en/Pharmaceuticals-Market-to-Reach-USD-1-310-0-Billion-in-2020-
Eruption-of-the-COVID-19-Pandemic-to-Accelerate-the-Demand-for-Effective-Treatments-and-Drugs-
Worldwide-Fortune-Business.html
5. EFFICACY OF DRUGS AND TREATMENT
• Efficacy - https://pharmanewsintel.com/news/ai-in-the-pharma-industry-current-uses-best-cases-
digital-future
• Clinical trials - https://imagia.com/machine-learning-understanding-differences-between-real-world-
evidence-and-clinical-trial-data-for-better-patient-outcomes-2/
• Hitting the bullseye - https://www.astrazeneca.com/what-science-can-do/topics/disease-
understanding/Hitting-the-bullseye-finding-better-targets-for-drug-development.html
6. VACCINE PRODUCTION
Top 10 – Vaccine Manufacturing
1. Glaxo Welcome
2. Merck and Company
3. Sanofi
4. Pfizer
5. Novavax
6. Emergent BioSolutions
7. CSL
8. Inovio Pharmaceuticals
9. Bavarian Nordic
10. Mitsubishi Tanabe
Source -
https://blog.technavio.com/blog/top-10-
vaccine-manufacturers
• Contract manufacturing -
https://www.contractpharma.com/contents/view_breaking-
news/2020-10-26/3p-biopharmaceuticals-and-spybiotech-enter-
vaccine-contract-manufacturing-agreement/
• Contract manufacturing -
https://www.contractpharma.com/content-microsite/covid-
19/2020-11-24/curevac-and-wacker-sign-contract-for-
manufacturing-of-covid-19-vaccine-candidate
• USA, Germany, and United Kingdom -
https://gmpnews.net/2020/11/us-uk-and-germany-are-top-
manufacturers-for-covid-19-vaccines/
• Mass production challenges -
https://www.cnbc.com/2020/11/18/what-are-the-big-
challenges-to-mass-producing-a-coronavirus-vaccine.html
• Vaccines / Australia - https://www.cslbehring.com/vita/2020/csl-
starts-manufacturing-a-potential-covid19-vaccine
• Japan / Takeda -
https://www.takeda.com/newsroom/newsreleases/2020/takeda-
expands-covid-19-vaccine-supply-in-japan-through--
partnership-with-moderna-and-government-of-japan/
7. VACCINATION LICENSING
• Regulations / Canada - https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/activities/fact-sheets/regulation-
vaccines-human-canada.html
• Biotech Canada / 2016 Paper
• In Canada, annual vaccine sales are estimated at roughly $Cdn 450 million. Recent data from the Canadian Institute for Health Information (CIHI) regarding Canada’s total health care spending
helps put vaccine spending into appropriate perspective; vaccine spending represents a small percentage (4.0%) of Canadian public health expenses, and an extremely small fraction (<0.3%) of
national health care expenditures in 2008
• Despite the tremendous value of vaccines – and their proven impact on public health – fewer companies are currently investing in the vaccine market sector worldwide. The global vaccine
industry has recently undergone significant consolidation; over the past 30 years, the number of companies engaged in the development and manufacturing of vaccines has declined from
roughly 25 to five. 44 Potential factors that have contributed to the decision for several companies to abandon their vaccine production lines (including, among other challenges, complexity of
development, production and quality control) are discussed in further detail in Paper 7 regarding manufacturing and supply issues.
• As of early 2009, the Canadian vaccine landscape mirrors the highly concentrated structure of the global vaccine marketplace, with the “top tier” vaccine companies currently including
GlaxoSmithKline (GSK) Canada, Merck Canada Ltd., Novartis, Pfizer Canada (formerly Wyeth Pharmaceuticals Canada), and Sanofi Pasteur. All these players represent Canadian divisions of the
respective multinational companies headquartered in Europe (GSK, Novartis, Sanofi Aventis) or the United States (Merck, Pfizer). While Sanofi Pasteur has a large-scale vaccine manufacturing
• facility based in Toronto (known as the Connaught Campus),45 GSK has vaccine production facilities in Québec City and Laval, Québec.46 These Canadian facilities supply vaccines for global
clinical trials and/or commercial sales (e.g. for influenza and acellular pertussis vaccines, by GSK and Sanofi Pasteur, respectively). Merck, Novartis, and Pfizer do not presently have vaccine
manufacturing facilities in Canada. Key vaccines of the five top tier companies that are currently available on the Canadian market are listed in Table 2.4. Further details are provided in Paper 5
(Tables 5.1 and 5.2) regarding these and other vaccines approved in Canada for infants, children,
• Source - www.biotech.ca
vaccines_2_2010.pdf
8. INNOVATION
• Storage/shipments of vaccines - Researchers in Ontario have developed a new method of transporting
life-saving vaccines to remote and impoverished regions of the world at only a fraction of the cost of
current techniques. The research team from McMaster University in Hamilton, Ont. has found a way to
eliminate current costly refrigeration methods or “cold-chain constant storage,” which stores vaccines
at a temperature between 2 C and 8 C in order to keep them viable. In a study published Tuesday in
the journal Scientific Reports, the academics share a new method of transportation that only requires
two sugars that are already approved by the U.S. Food and Drug Administration (FDA) and Health
Canada. Leung said they mix the two sugars -- trehalose and pullulan – together with existing vaccines
into a sugary gel. The combination allows the active ingredients in the vaccines to remain viable for
eight weeks or more in elevated temperatures up to 40 C, according to the researchers. Source -
https://www.ctvnews.ca/health/new-made-in-canada-technique-could-revolutionize-vaccine-
transportation-1.4430517
• Vaccine production / innovation - https://www.mckinsey.com/industries/pharmaceuticals-and-medical-
products/our-insights/refueling-the-innovation-engine-in-vaccines#
• USA / Warp Speed - https://www.hhs.gov/coronavirus/explaining-operation-warp-speed/index.html
10. BLOG – NEAR-SHORING
A trade war with China and the disruptive effects of the COVID-19 pandemic have U.S. companies starting to question a decades-old strategy of
shifting manufacturing operations to low-cost labor markets in China and other Asian nations.
Some are starting to invest in expanding or building new factories in the U.S. and its nearby trade partners, Mexico, and Canada. Such moves are
known as reshoring — for the U.S. — and nearshoring in Mexico and Canada. If the trend accelerates, it will create a domestic manufacturing boom
and alter trucking routes, shifting some import-centric traffic from Southern California’s massive port complex to manufacturing hubs across the
U.S., according to analysts.
A June survey by Thomas, a New York-based industrial sourcing platform, found that 69% of businesses said they are “likely” to “extremely likely”
to re-shore operations to bolster their supply chains — up from 54% in a previous survey in February, just before the pandemic took hold. Source -
https://www.ttnews.com/articles/2020-events-force-manufacturers-rethink-reshoring-operation-plans
Summary
• All levels of government need to work together to develop economic policies that will support the reshoring of critical parts of the supply chain
• It is very competitive when it comes to attracting foreign direct investment (FDI). Countries need to take a hard look at their policies related to
regulations and taxes - https://www.slideshare.net/paulyoungcga/path-to-innovation-for-canada
Here is my work on supply chain - https://www.slideshare.net/paulyoungcga/how-best-to-reshore-your-supply-chain-management-system-
241186222
11. LIFE SCIENCES STRATEGY
Pandemic-preparedness plan can be start of life-sciences strategy -
https://www.linkedin.com/pulse/pandemic-preparedness-plan-can-start-life-sciences-strategy-
young/?published=t
There are many pieces to a life-sciences strategy including the coordinating of biotech/pharmaceuticals on drug research and
discovery, expanding AI into the drug discovery process, etc.
Here is my work on biotech/pharmaceutical: https://www.slideshare.net/paulyoungcga/biotech-and-pharmaceutical-
september-2021
There are also issues with how both the private and public sectors deal with geopolitical events including crisis management.
I have called out the following issues:
a) Lack of audited crisis management reports and processes for all levels of governments
b) Lack of oversight including performance audits of WHO
c) Lack of homegrown vaccination production
d) Lack of exit strategy when it comes to transitioning off pandemic programs
e) Lack of focus on protecting the environment while growing the economy in a sustainable way
f) Lack of building a resilient supply chain
g) Revamping EI plans as part of transitioning people to do jobs of today and tomorrow
Blog – Geopolitical Risks and Events – Global Viruses (Healthcare) – October 22, 2021 -
https://www.slideshare.net/paulyoungcga/geopolitical-eventscovid19canada-and-the-world-october-22-2021
12. DATA, AI, SECURITY AND PHARMACEUTICALS
• IBM and peptides - https://www.ibm.com/blogs/research/2021/03/ai-finds-new-peptides/
• Close, consolidate and reporting - https://ibm.box.com/s/i7efp948qvb5l8bt96y8sigsup8yes2u
• HIPAA - https://compliancy-group.com/hipaa-compliance-and-ai-solutions/
• Rules around accessing data and how it is to be used
• Disease Management
• Data and AI - https://www.pwc.com/gx/en/industries/healthcare/publications/ai-robotics-new-health/transforming-
healthcare.html
• Online Pharmacies - Market Research Future (MRFR) evaluates that the Global ePharmacy Market is
anticipated to acquire a market value of USD 164,829.5 Million while expanding at a CAGR of 12.5% by
2027.
• AI can play a role in terms of data governance and oversight -
https://ibm.box.com/s/noi1j6ixzl6ralxkm4g0zzs911wf6s76
13. BIOTECH AND PHARMA AI
On Mar. 16, Amgen announced that it had entered a multi-year partnership with Mila – Quebec Artificial
Intelligence Institute. As a global biotechnology company, Amgen uses science and technology to discover and
develop therapeutics, and AI is currently deployed in several of its R&D and manufacturing activities. This new
partnership will permit Amgen to expand its knowledge of AI and deep learning by interacting and engaging with
experts in Mila’s unique ecosystem, both virtually and (eventually) on the Mila campus in Montreal. This
announcement was made during Effervescence 2021, an international virtual gathering of scientists, entrepreneurs
and industry professionals from the life sciences and health technology sectors in the presence of the Quebec
Minister of Economy and Innovation, Pierre Fitzgibbon.
Source - https://www.canadianmanufacturing.com/manufacturing/amgen-announces-artificial-intelligence-
partnership-with-mila-267908/
14. BLOG - AI-BASED IMAGING ANALYSIS TOOLS AND
CLOUD-BASED DEPLOYMENTS TO BOLSTER
DIGITAL PATHOLOGY MARKET
• AI-Based imaging analysis tools and cloud-based deployments to bolster digital
pathology market – Healthcare and Drug Discovery and Pharmacy
Management - https://www.linkedin.com/pulse/blog-ai-based-imaging-
analysis-tools-cloud-based-bolster-paul-young
16. SUMMARY
• DNA Storage – Biotech and Pharma - https://www.nextbigfuture.com/2021/06/new-dna-data-
storage.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+blogspot%2Fadvanc
ednano+%28nextbigfuture%29
• More and more work will be done as part of cutting down the drug discovery cycle
• More and more vaccine production will be move back to domestic markets as part of mitigating risks from
the next virus.
Blog – Pharmaceutical and Biotech – What is next
Pharma to lead
blockchain adoption in supply chain - Express Pharma.pdf
Future for
Pharmaceutical Manufacturers Includes More Digitized Data Collection Healthcare Packaging.pdf
Data automation
startup Veda gets $45M boost to help reduce healthcare overhead costs Fierce Healthcare.pdf
Industry
Voices—How AI is solving some of healthcare's biggest challenges during the pandemic Fierce Healthcare.pdf
Moderna plots
vaccines against 15 pathogens with future pandemic potential Reuters.pdf
Government and
industry commit to pandemic-proofing - Research Professional News.pdf
Moderna will provide
access to mRNA tech, but high-income countries will have to pay Fierce Pharma.pdf
Two long years of
Covid-19 lasting questions for pharma and healthcare.pdf
Software Supply
Chain Security Turns to Risk Mitigation.pdf
Clarivate Deals
Report Highlights Emerging Trends in Biopharma Deal-Making.pdf
Digitization could
drive manufacturing beyond Industry 4.0 VentureBeat.pdf
Pharma ESG efforts
overwhelmingly skew social, while environment and governance come up short study Fierce Pharma.pdf
More focus will be on gene and immune therapy
Data and AI will continue to play a key role in the mapping of genes
Governments around the world need to address gaps with their healthcare delivery model
WHO needs to do a better job mitigating the spread of diseases and variants?
1. Future pandemics - https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-
plots-vaccines-against-15-pathogens-with-future-pandemic-potential-2022-03-08/
2. Pandemic proofing - https://www.researchprofessionalnews.com/rr-news-uk-innovation-2022-
3-government-and-industry-commit-to-pandemic-proofing/
3. MRNA - https://www.fiercepharma.com/pharma/moderna-will-provide-access-technology-
spikevax-high-income-countries-will-have-pay
4. Healthcare and Pandemics - https://www.pharmaceutical-technology.com/features/two-long-
years-of-covid-19-lasting-questions-for-pharma-and-healthcare/
5. Risk Mitigation - https://www.nationaldefensemagazine.org/articles/2022/3/8/software-supply-
chain-security-turns-to-risk-mitigation
6. Trends - https://www.newswire.ca/news-releases/clarivate-deals-report-highlights-emerging-
trends-in-biopharma-deal-making-835608549.html
7. Industry 4.0 - https://venturebeat.com/2022/03/12/digitization-could-drive-manufacturing-
beyond-industry-4-0/
8. ESG - https://www.fiercepharma.com/marketing/pharma-esg-efforts-overwhelmingly-skew-
social-while-environment-and-governance-come-up
9. Supply chain - https://www.expresspharma.in/pharma-to-lead-blockchain-adoption-in-supply-
chain/
10. Manufacturing -
https://www.healthcarepackaging.com/markets/pharmaceutical/article/22105856/pmmi-
future-for-pharmaceutical-manufacturers-includes-more-digitized-data-collection
11. Healthcare crisis - https://www.fiercehealthcare.com/tech/data-automation-startup-veda-gets-
45m-boost-to-help-reduce-healthcare-overhead-costs
12. AI - https://www.fiercehealthcare.com/tech/industry-voices-how-ai-solving-some-healthcare-s-
biggest-challenges-during-pandemic
17. TRAINING AND DEVELOPMENT
• If you like to learn more
about trade and/or other
subjects as part of your
professional learning and
development then feel
free to review my material
on
https://www.udemy.com/
(search Paul Young CPA
CGA)
• These subjects address
how to fixed issues with
housing and/or systemic
issues related to economy
including government
policies